Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine

Nuclear Medicine and Biology

Volumn 38, Issue 6, 2011, Pages 867-874

  Fu, Yan ^a   Létourneau, Myriam ^a   Chatenet, David ^a   Dupuis, Jocelyn ^b,c   Fournier, Alain ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adrenomedullin; Iodination; Lactoperoxidase; Lung imaging; Receptor binding

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN TYROSINE I 125; CARBOXYPEPTIDASE C; CYANOGEN BROMIDE; IODINATED CONTRAST MEDIUM; LACTOPEROXIDASE; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DOG; ENZYME METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTHERM; LIGAND BINDING; LUNG; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; RADIOIODINATION; RECEPTOR BINDING;

ADRENOMEDULLIN; ANIMALS; BINDING SITES; DOGS; HUMANS; IODINE; LACTOPEROXIDASE; LUNG; NUCLEAR MEDICINE; ORGANOTECHNETIUM COMPOUNDS; OXIDATION-REDUCTION; SUBSTRATE SPECIFICITY;

EID: 80051696783     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.01.011     Document Type: Article

References (28)

1. Harel F., Fu Y., Nguyen Q.T., Letourneau M., Perrault L.P., Caron A., et al. Use of adrenomedullin derivatives for molecular imaging of pulmonary circulation. J Nucl Med 2008, 49:1869-1874.
2. Fu Y., Letourneau M., Nguyen Q.T., Chatenet D., Dupuis J., Fournier A. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. Eur J Pharmacol 2009, 617:118-123.
3. Dupuis J., Harel F., Fu Y., Nguyen Q.T., Letourneau M., Prefontaine A., et al. Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin. J Nucl Med 2009, 50:1110-1115.
4. Barbera J.A., Blanco I. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management. Drugs 2009, 69:1153-1171.
5. Brain S.D., Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004, 84:903-934.
6. Nikitenko L.L., Fox S.B., Kehoe S., Rees M.C., Bicknell R. Adrenomedullin and tumour angiogenesis. Br J Cancer 2006, 94:1-7.
7. Kaafarani I., Fernandez-Sauze S., Berenguer C., Chinot O., Delfino C., Dussert C., et al. Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice. FASEB J 2009, 23:3424-3435.
8. Sakata J., Asada Y., Shimokubo T., Kitani M., Inatsu H., et al. Adrenomedullin in the gastrointestinal tract. Distribution and gene expression in rat and augmented gastric adrenomedullin after fasting. J Gastroenterol 1998, 33:828-834.
9. Lewis L.K., Smith M.W., Yandle T.G., Richards A.M., Nicholls M.G. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998, 44:571-577.
10. Chakravarty P., Suthar T.P., Coppock H.A., Nicholl C.G., Bloom S.R., Legon S., et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol 2000, 130:189-195.
11. Eguchi S., Hirata Y., Kano H., Sato K., Watanabe Y., Watanabe T.X., et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994, 340:226-230.
12. Aubin J., Letourneau M., Francoeur E., Burgeon E., Fournier A. Identification of ETA and ETB binding domains using ET-derived photoprobes. Biochimie 2008, 90:918-929.
13. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A., et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995, 136:2127-2134.
14. Buscombe J., Hirji H., Witney-Smith C. Nuclear medicine in the management of thyroid disease. Expert Rev Anticancer Ther 2008, 8:1425-1431.
15. Bohndiek S.E., Brindle K.M. Imaging and 'omic' methods for the molecular diagnosis of cancer. Expert Rev Mol Diagn 2010, 10:417-434.
16. Goldsmith S.J. Update on nuclear medicine imaging of neuroendocrine tumors. Future Oncol 2009, 5:75-84.
17. Murthy K.K., Thibault G., Schiffrin E.L., Garcia R., Chartier L., Gutkowska J., et al. Disappearance of atrial natriuretic factor from circulation in the rat. Peptides 1986, 7:241-246.
18. Loot A.E., van Buiten A., Roks A.J., Henning R.H. The suitability of iodinated angiotensin-(1-7) peptides as pharmacological tools. J Pharmacol Toxicol Methods 2005, 51:51-55.
19. Tessier S., Boivin S., Aubin J., Lampron P., Detheux M., Fournier A. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Biochemistry 2005, 44:7844-7854.
20. Leprince J., Chatenet D., Dubessy C., Fournier A., Pfeiffer B., Scalbert E., et al. Structure-activity relationships of urotensin II and URP. Peptides 2008, 29:658-673.
21. 9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Peptides 2009, 30:1130-1136.
22. Morikawa S., Kanatani A., Kobayashi R., Yoshimoto T., Tsuru D. Chemical modification of neutral protease from Bacillus subtilis var. amylosacchariticus: assignment of tyrosyl residues iodinated. Agric Biol Chem 1991, 55:2751-2756.
23. Rosenfeld R., Philo J.S., Haniu M., Stoney K., Rohde M.F., Wu G.M., et al. Sites of iodination in recombinant human brain-derived neurotrophic factor and its effect on neurotrophic activity. Protein Sci 1993, 2:1664-1674.
24. Eguchi S., Hirata Y., Iwasaki H., Sato K., Watanabe T.X., Inui T., et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994, 135:2454-2458.
25. Belloni A.S., Andreis P.G., Meneghelli V., Champion H.C., Kadowitz P.J., Coy D.H., et al. Adrenomedullin and calcitonin gene-related peptide (CGRP) interact with a common receptor of the CGRP1 subtype in the human adrenal zona glomerulosa. Endocr Res 1999, 25:29-34.
26. Coppock H.A., Owji A.A., Austin C., Upton P.D., Jackson M.L., Gardiner J.V., et al. Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. Biochem J 1999, 338(Pt 1):15-22.
27. Dang K., Disa J., Gout B., Aiyar N. Comparative affinities of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) for [125I] AM and [125I] CGRP specific binding sites in porcine tissues. J Recept Signal Transduct Res 1999, 19:803-817.
28. Kennedy S.P., Sun D., Oleynek J.J., Hoth C.F., Kong J., Hill R.J. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem Biophys Res Commun 1998, 244:832-837.